REGISTER FOR THE RARE DIEM CONFERENCE HERE
“Mirum Pharmaceuticals is committed to developing safe and effective therapies for people with rare liver diseases. Ultimately, they want to help patients and their families experience a brighter future,” said Sara Tylosky, CEO Farmacon Global. “Mirum, like each of our distinguished participants, is dedicated to solutions for patients in the rare disease realm.
“In the case of the second annual Rare Diem Conference on August 25th, our focal-point will be access to Rare Disease solutions in the evolving market of Latin America, which is a region of 660 million people with an epidemiological profile resembling that of the Unites States – as well as diversity profiles, including rare disease when sought. Navigating the unique cultural and logistical challenges of access to rare disease solutions in Latin American and evolving markets is our specialty. From this unique position, we are able, with the help of Mirum Pharmaceuticals’ sponsorship to present experts from across Latin America in this conversation.
“Prestigious speakers such as Dick Salvatierra, Founder and President of Americas Health Foundation, collaborating for the future of healthcare in Latin America will lend valuable insights. Panelists also include Antoine Daher, Founder and President of Casa Hunter in Brazil, accustomed to working government policy to assist rare disease patients. In all, the Rare Diem conference will bring together experts in the pharmaceutical industry, the medical community, patients with rare medical conditions, advocacy leaders and government representatives to analyze advances in research and access to treatments in these evolving markets. Join the conversation,” said Tylosky.
For more information on Rare Diem and how to register,contact Sara Tylosky, CEO Farmacon Global or Carlos Martínez Villela 561-232-3441
